Chatchada Karanes, MD

home / authors / chatchada-karanes-md

Articles

Chatchada Karanes, MD;Dennis Confer, MD;Tim Walker, MA;Andrea Askren, MA;Claire Keller, RN

August 1st 2003

Approximately 70% of patientswith life-threatening diseasestreatable with allogeneic bloodstem cell transplantation do not havematched related donors. The NationalMarrow Donor Program (NMDP) wasestablished in 1986 to provide humanleukocyte antigen (HLA)-matched,volunteer unrelated donors for thesepatients. The NMDP performs thistask by maintaining a registry of morethan 4.9 million volunteer donors ofmarrow and peripheral blood stemcells (PBSC) and 12 cord blood bankscontaining more than 25,000 units ofumbilical cord blood.

High-Dose Chemotherapy With Autologous Stem Cell Rescue in the Outpatient Setting

William P. Peters, MD, PhD;Roy B. Baynes, MD, PhD;Roger Dansey, MD;Jared Klein, MD;Caroline Hamm, MD;Chatchada Karanes, MD;Steve Abella, MD

January 2nd 2000

Outpatient bone marrow transplant (BMT) strategies, as reviewed by Dix and Geller, have evolved for various reasonsfrom social to medical. If high-dose approaches are to become a viable treatment for common cancers, such as breast cancer, the refinement of transplants to a kinder and gentler approach is essential.